The effect of arginine supplementation on growth hormone release and intestinal mucosal growth after massive small bowel resection in growing rats.
Four-week-old male Sprague-Dawley rats underwent a 90% small bowel resection. From the fourth day after surgery, they were divided into group 1 and 2, and pair-fed by elemental diets (0.8 kcal/mL, 50 mL/day) with L-arginine (n = 10) or L-glycine (n = 11) as an isonitrogenous and isoenergetic supplement for 3 weeks. They were compared with each other 3 weeks after surgery. A statistical analysis was performed using the unpaired Student's t test and the one-way factorial analysis of variance (ANOVA) using Bonferroni/Dunn multiple comparison test. A Pvalue of < .05 was considered significant. There were no significant differences between the two groups in food intake, body weight, tail length, residual ileal length, and plasma IGF-I level. However, the mean height of ileal villi in group 1 showed higher than that in group 2 (P < .01). Growth hormone-releasing hormone (GHRH) provocative tests (1 microg per rat, intravenously) showed the more significant elevation of growth hormone IGH) secretion in the arginine supplement group than that of glycine supplement group at 5 minutes (P < .05). There were no significant differences between basal levels of plasma rat GH in both groups. It is suggested that arginine has a possible significant role of GH secretion and intestinal mucosal growth after massive small bowel resection.
Hebiguchi
T
T
Department of Pediatric Surgery, Akita University School of Medicine, Japan.
Kato
T
T
Yoshino
H
H
Mizuno
M
M
Koyama
K
K
D000818:Animals; D000831:Animals, Newborn; D001120:Arginine / Q000494:pharmacology*; D005527:Food, Fortified; D013006:Growth Hormone / Q000378:metabolism*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000254:growth & development*; D007421:Intestine, Small / Q000601:surgery*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley
D013006:Growth Hormone; D001120:Arginine